Anticoagulation control in Malaysia: Reports of time in therapeutic range, bleeding, and thromboembolic complications

被引：0
|
作者：
Mazlan-Kepli, W. [1 ]
Mohamed, S. [2 ]
Nik-Ismail, N. A. [3 ]
Nagarajah, J. R. [4 ]
机构：
[1] Univ Malaya, Dept Clin Pharm & Pharm Practice, Fac Pharm, Kuala Lumpur 50603, Malaysia
[2] Minist Hlth Malaysia, Hosp Serdang, Dept Pharm, Jalan Puchong, Kajang 43000, Selangor, Malaysia
[3] Minist Hlth Malaysia, Hosp Raja Perempuan Zainab II, Dept Pharm, Jalan Hosp, Kota Baharu 15200, Kelantan, Malaysia
[4] Minist Hlth Malaysia, Hosp Kuala Lumpur, Dept Pharm, Jalan Pahang, Kuala Lumpur 50586, Wilayah Perseku, Malaysia
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2022年 / 369卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
24
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [21] Implementation of anticoagulation centers of excellence standards to improve time in therapeutic range
    Thomas, Ashley M.
    Naik, Nilam
    Ragheb, Bishoy
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 47 (04) : 618 - 619
  • [22] ANTICOAGULATION IN ADULT ECMO: PERCENTAGE OF TIME IN THERAPEUTIC RANGE WITH HEPARIN OR BIVALIRUDIN
    Slampak-Cindric, Angela
    Demerdash, Amin
    Stamm, Jason
    Mehta, Yatin
    Berger, Andrea
    Gajkowski, Evan
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 396 - 396
  • [23] Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolation
    van den Besselaar, A. M. H. P.
    Biedermann, Joseph S.
    van der Meer, Felix J. M.
    Adriaansen, Henk J.
    Leebeek, Frank W. G.
    Kruip, Marieke J. H. A.
    THROMBOSIS AND HAEMOSTASIS, 2016, 116 (04) : 679 - 686
  • [24] Anticoagulation Control in Swiss Primary Care: Time in Therapeutic Range Percentages Exceed Benchmarks of Phase III Trials
    Djalali, Sima
    Valeri, Fabio
    Gerber, Bernhard
    Meli, Damian N.
    Senn, Oliver
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (06) : 685 - 695
  • [25] Comparison of time within therapeutic INR range with percentage INR within therapeutic range for assessing long-term anticoagulation control in children: reply to a rebuttal
    Biss, T. T.
    Avery, P. J.
    Walsh, P. M.
    Kamali, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) : 2332 - 2333
  • [26] A comparison of two efficacy measures of anticoagulation therapy: time in therapeutic range and percent of tests in range
    Wurster, Mark W.
    Heydman, Matthew
    Chopin, Barbara
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 394 - 394
  • [27] Early Anticoagulation Bridging to Therapeutic International Normalized Ratio after Left Ventricular Assist Device Implantation is Not Associated with Thromboembolic and Bleeding Complications: A Systematic Review and Meta-Analysis
    Kittipibul, V.
    Angsubhakorn, N.
    Kewchareon, J.
    Prasitlumkum, N.
    Rattanawong, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S192 - S192
  • [28] Risk-adjusted perioperative bridging anticoagulation reduces bleeding complications without increasing thromboembolic events in general and visceral surgery
    Doehler, Ida
    Roeder, Daniel
    Schlesinger, Tobias
    Nassen, Christian Alexander
    Germer, Christoph-Thomas
    Wiegering, Armin
    Lock, Johan Friso
    BMC ANESTHESIOLOGY, 2023, 23 (01)
  • [29] Risk-adjusted perioperative bridging anticoagulation reduces bleeding complications without increasing thromboembolic events in general and visceral surgery
    Ida Döhler
    Daniel Röder
    Tobias Schlesinger
    Christian Alexander Nassen
    Christoph-Thomas Germer
    Armin Wiegering
    Johan Friso Lock
    BMC Anesthesiology, 23
  • [30] Intraprostatic injection of tranexamic acid to control refractory bleeding while maintaining therapeutic anticoagulation
    Le, Brian
    Knoedler, Margaret
    Roberge, Gray
    UROLOGY CASE REPORTS, 2020, 28
12345